Finance

Beta
Lists
688073:SHA
Bide Pharmatech Co Ltd
CN¥49.70
+1.64%
(+0.80) 1D
Jun 26, 3:00:05 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688073...
Open
CN¥48.49
High
CN¥51.85
Low
CN¥48.48
Mkt. cap
4.52B
Avg. vol.
1.43M
Volume
3.13M
Dividend
2.33%
Quarterly dividend
CN¥0.29
Ex-dividend date
Jun 10, 2026
P/E ratio
25.39
52-wk high
CN¥82.88
52-wk low
CN¥43.21
EPS
CN¥1.96
No. of employees
734
Open
CN¥48.49
High
CN¥51.85
Low
CN¥48.48
Mkt. cap
4.52B
Avg. vol.
1.43M
Volume
3.13M
Dividend
2.33%
Quarterly dividend
CN¥0.29
Ex-dividend date
Jun 10, 2026
P/E ratio
25.39
52-wk high
CN¥82.88
52-wk low
CN¥43.21
EPS
CN¥1.96
No. of employees
734
News stories
From sources across the web
About Bide Pharmatech Co Ltd
CEO-
Employees734
FoundedApr 27, 2007
Headquarters-
SectorPharmaceutical industry
Websitebidepharmatech.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
331.15M
351.58M
344.70M
323.28M
Cost of goods sold
201.58M
177.36M
229.41M
165.25M
Cost of revenue
201.58M
177.36M
229.41M
165.25M
Research and development expenses
10.45M
20.44M
13.41M
14.99M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
72.64M
69.10M
85.46M
68.86M
Operating expense
90.28M
78.83M
110.37M
81.39M
Total operating expenses
291.87M
256.19M
339.78M
246.63M
Operating income
39.28M
95.39M
4.92M
76.64M
Other non operating income
-2.39M
-8.48M
7.57M
-15.67M
EBT including unusual items
57.49M
58.72M
35.86M
61.38M
EBT excluding unusual items
40.15M
92.94M
-1.67M
64.07M
Income tax expense
14.78M
12.39M
3.86M
14.55M
Effective tax rate
25.71%
21.11%
10.75%
23.71%
Other operating expenses
2.36M
-9.25M
11.14M
-3.21M
Net income
42.71M
46.33M
32.01M
46.83M
Net profit margin
12.90%
13.18%
9.29%
14.49%
Earnings per share
-
-
-
-
Interest and investment income
7.36M
4.30M
4.95M
4.19M
Interest expense
-1.33M
-1.05M
-1.18M
-1.10M
Net interest expenses
6.04M
3.25M
3.78M
3.10M
Depreciation and amortization charges
-
-
-
-
EBITDA
42.58M
98.11M
8.47M
80.20M
Gain or loss from assets sale
-330.57K
330.57K
-3.90M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of 688073
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer